臨床試驗

CIRSE Registry for SIR-Spheres Therapy

NCT：NCT02305459 · COMPLETED

NCT IDNCT02305459

狀態COMPLETED

完成時間2020-01-01

SponsorCardiovascular and Interventional Radiological Society of Europe (OTHER)

First posted2014-12-02

Last updated2026-05-14

簡要摘要

The administration of SIR-Spheres microspheres (yttrium-90 resin microspheres) is a form of selective internal radiation therapy (SIRT) for the treatment of patients with primary and secondary liver tumours. The primary objective is to observe the real-life clinical application of radioembolisation with SIR-Spheres and the impact of the treatment in clinical practice. Secondary objectives are to observe safety and effectiveness of SIR-Spheres treatment in terms of adverse events, Overall Survival (OS), Progression-free survival (PFS), technical considerations, liver PFS and Quality of Life (QoL) + subgroup analyses

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。